
Novo Nordisk Cuts Prices for Ozempic and Wegovy
Novo Nordisk, a notable pharmaceutical company, has made the decision to substantially reduce the U.S. list prices for its popular diabetes and weight-loss drugs, Ozempic and Wegovy. This announcement came during the segment ‘America Reports’ featuring Dr. Mahsa Tehrani, a board-certified rheumatologist. Recently, a novel weight-loss trend has emerged, involving the consumption of a mixture […]








